Manufacturers seeking to employ these methods must supply strong validation information to exhibit their equivalence to pharmacopoeial methods. As these new technologies arise, the WHO emphasizes the value of a thorough possibility evaluation and validation approach. The WHO guidelines encourage the adoption of those systems, supplied they can be waiting for link from Forum Profiles (11)